KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Tenet Healthcare (THC) Interest Expenses (2016 - 2025)

Tenet Healthcare's Interest Expenses history spans 17 years, with the latest figure at $206.0 million for Q2 2025.

  • For Q2 2025, Interest Expenses rose 1.48% year-over-year to $206.0 million; the TTM value through Dec 2025 reached $410.0 million, down 50.36%, while the annual FY2025 figure was $821.0 million, 0.61% down from the prior year.
  • Interest Expenses for Q2 2025 was $206.0 million at Tenet Healthcare, up from $204.0 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $240.0 million in Q1 2021 and bottomed at $202.0 million in Q3 2024.
  • The 5-year median for Interest Expenses is $221.5 million (2021), against an average of $219.4 million.
  • The largest annual shift saw Interest Expenses decreased 13.69% in 2021 before it increased 3.65% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $221.0 million in 2021, then dropped by 0.9% to $219.0 million in 2022, then rose by 3.65% to $227.0 million in 2023, then decreased by 10.57% to $203.0 million in 2024, then grew by 1.48% to $206.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Interest Expenses are $206.0 million (Q2 2025), $204.0 million (Q1 2025), and $203.0 million (Q4 2024).